PRODUCT DETAIL

Sitagliptin/Metformin Krka 50 mg/850 mg filmom obalené tablety

Code

9096D

MA number

18/0023/21-S

Product Form:

tbl flm 200x50 mg/850 mg (blis.PVC/PE/PVDC/PE/PVC/Al)

MA Status:

R - Valid Marketing Authorisation

Type of procedure:

Decentralised

Therapeutic Class:

18 - ANTIDIABETICA (VRÁTANE INZULÍNU)

ATC:

A	ALIMENTARY TRACT AND METABOLISM
A10	DRUGS USED IN DIABETES
A10B	Blood glucose lowering drugs, excl. insulins
A10BD	Combinations of oral blood glucose lowering drugs
A10BD07	Metformin and sitagliptin

Shelf life:

Route of admin.:

Oral use

Prescription Status:	Medicinal product subject to medical prescription.
Legal basis:	Article 10(1) generic application
MA issued:	09.02.2021
Validity:	09.02.2026
Dokument:	VHS Sitagliptin_Metformin Krka.pdf
Dokument:	VHS_súhrn Sitagliptin_Metformin Krka.pdf
SPC:	SPC_Sitagliptin_Metformin Krka _filmom obalené tablety_03.2024.pdf
PIL:	PIL_Sitagliptin_Metformin Krka _filmom obalené tablety_03.2024.pdf
Safety feature	Yes
Data update:	22.06.2023